Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole (Q56339150)
article by Anu Varhe et al published December 1994 in Clinical Pharmacology & Therapeutics
Language:
Current Data About Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole
(P31) (Q13442814)

(P304) 601-607

(P407) (Q1860)

(P433) 6

(P478) 56

(P577) +1994-12-00T00:00:00Z

(P921) (Q181600)

(P1433) (Q1101529)

(P1476) "Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole" (language: en)

(P2093) Anu Varhe
(P1545) 1

Klaus T Olkkola
(P1545) 2

Pertti J Neuvonen
(P1545) 3

other details
description article by Anu Varhe et al published December 1994 in Clinical Pharmacology & Therapeutics

External Links
(P356) 10.1038/CLPT.1994.184
(P698) 7995001